Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,970 | 2 | 64.1% |
| Honoraria | $3,900 | 1 | 22.8% |
| Food and Beverage | $1,169 | 17 | 6.8% |
| Travel and Lodging | $1,014 | 4 | 5.9% |
| Education | $55.49 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sarepta Therapeutics, Inc. | $12,555 | 15 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $4,063 | 5 | $0 (2024) |
| Biogen, Inc. | $152.05 | 2 | $0 (2024) |
| PTC Therapeutics, Inc. | $144.40 | 2 | $0 (2022) |
| Eisai Inc. | $115.49 | 1 | $0 (2017) |
| BioMarin Pharmaceutical Inc. | $78.34 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,106 | 13 | Sarepta Therapeutics, Inc. ($7,932) |
| 2022 | $98.10 | 2 | Sarepta Therapeutics, Inc. ($75.00) |
| 2021 | $121.30 | 1 | PTC Therapeutics, Inc. ($121.30) |
| 2019 | $78.34 | 1 | BioMarin Pharmaceutical Inc. ($78.34) |
| 2018 | $42.00 | 1 | Biogen, Inc. ($42.00) |
| 2017 | $4,663 | 8 | Sarepta Therapeutics, Inc. ($4,548) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Education | Cash or cash equivalent | $13.49 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Honoraria | Cash or cash equivalent | $3,900.00 | General |
| Category: NEUROLOGY | ||||||
| 09/28/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Food and Beverage | Cash or cash equivalent | $75.00 | General |
| Category: NEUROLOGY | ||||||
| 09/28/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: NEUROLOGY | ||||||
| 09/28/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: NEUROLOGY | ||||||
| 06/20/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Consulting Fee | Cash or cash equivalent | $7,470.00 | General |
| Category: Genetic Disease | ||||||
| 06/15/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Food and Beverage | In-kind items and services | $60.82 | General |
| Category: Genetic Disease | ||||||
| 06/15/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Food and Beverage | In-kind items and services | $47.70 | General |
| Category: Genetic Disease | ||||||
| 06/15/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Genetic Disease | ||||||
| 06/15/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Genetic Disease | ||||||
| 06/14/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Travel and Lodging | In-kind items and services | $215.46 | General |
| Category: Genetic Disease | ||||||
| 03/04/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $110.05 | General |
| Category: Neurology | ||||||
| 03/04/2024 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $85.00 | General |
| 06/14/2022 | PTC Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.10 | General |
| 03/15/2022 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 12/06/2021 | PTC Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $121.30 | General |
| 12/05/2019 | BioMarin Pharmaceutical Inc. | Vimizim (Biological) | Food and Beverage | In-kind items and services | $78.34 | General |
| Category: MPS IVA | ||||||
| 04/16/2018 | Biogen, Inc. | SPINRAZA (Biological) | Education | In-kind items and services | $42.00 | General |
| Category: NEUROLOGY | ||||||
| 05/31/2017 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $115.49 | General |
| Category: Neurology | ||||||
| 02/04/2017 | Sarepta Therapeutics, Inc. | EXONDYS 51 (Drug) | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: Genetic Disease | ||||||
| 02/04/2017 | Sarepta Therapeutics, Inc. | EXONDYS 51 (Drug) | Travel and Lodging | In-kind items and services | $332.00 | General |
| Category: Genetic Disease | ||||||
| 02/04/2017 | Sarepta Therapeutics, Inc. | EXONDYS 51 (Drug) | Travel and Lodging | In-kind items and services | $300.00 | General |
| Category: Genetic Disease | ||||||
| 02/04/2017 | Sarepta Therapeutics, Inc. | EXONDYS 51 (Drug) | Travel and Lodging | In-kind items and services | $167.00 | General |
| Category: Genetic Disease | ||||||
| 02/04/2017 | Sarepta Therapeutics, Inc. | EXONDYS 51 (Drug) | Food and Beverage | In-kind items and services | $51.00 | General |
| Category: Genetic Disease | ||||||
| 02/04/2017 | Sarepta Therapeutics, Inc. | EXONDYS 51 (Drug) | Food and Beverage | In-kind items and services | $48.00 | General |
| Category: Genetic Disease | ||||||
About Dr. Kenneth Silver, MD
Dr. Kenneth Silver, MD is a Neurodevelopmental Disabilities healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871661686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Silver, MD has received a total of $17,109 in payments from pharmaceutical and medical device companies, with $12,106 received in 2024. These payments were reported across 26 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($10,970).
Practice Information
- Specialty Neurodevelopmental Disabilities
- Location Chicago, IL
- Active Since 12/01/2006
- Last Updated 03/14/2013
- Taxonomy Code 2080P0008X
- Entity Type Individual
- NPI Number 1871661686
Products in Payments
- Elevidys (Drug) $7,847
- EXONDYS 51 (Drug) $4,548
- AGAMREE (Drug) $4,063
- SPINRAZA (Biological) $152.05
- Fycompa (Drug) $115.49
- Vimizim (Biological) $78.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurodevelopmental Disabilities Doctors in Chicago
Nikolas Mata-Machado, M.d, M.D
Neurodevelopmental Disabilities — Payments: $5,730
Dr. Alan Rosenblatt, M.d, M.D
Neurodevelopmental Disabilities — Payments: $757.08
Anisa Kelley, Md, MD
Neurodevelopmental Disabilities — Payments: $248.52
Dr. Joshua Ewen, M.d, M.D
Neurodevelopmental Disabilities — Payments: $74.07
Dr. Helen Morrison, M.d, M.D
Neurodevelopmental Disabilities — Payments: $25.00
Teresa Sripada, M.d, M.D
Neurodevelopmental Disabilities — Payments: $19.48